BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lonza Biologics Inc. 

97 South Street

Hopkinton  Massachusetts  01748  U.S.A.
Phone: 508-497-0700 Fax: 508-435-8498


SEARCH JOBS



Who we are
Lonza Biologics Inc. in Hopkinton, Massachusetts and Portsmouth, New Hampshire, are part of the Lonza Group headquartered in Basel, Switzerland, a leading participant in the global biotechnology industry since 1980.

Where we are
Hopkinton is a historic town of approximately 15,000 people, located west of Boston. Hopkinton gains widespread media attention each year in April when the internationally famous Boston Marathon is run as the town is at the starting line of this 26-mile run to Boston. With easy access to New England’s many attractions such as Boston city life, Cape Cod, New Hampshire lakes and the beaches of Rhode Island, Hopkinton is a location offering something for everyone. Portsmouth, New Hampshire is located on the seacoast of New Hampshire with easy access to Boston, the White Mountains, Lakes and Maine.

What we do
In our New England Operations, our regulatory-approved sites provide process development, analytical and cGMP manufacturing services for the production of active biopharmaceutical ingredients for clinical trials as well as commercial products. With both Microbial and Mammalian manufacturing capability in New England, we provide a full range of manufacturing capacity from small clinical scale up through 20,000 liter scale for commercial supply. Lonza New England is home to over 1100 of Lonza Group’s 11,000 employees worldwide.

With global operations, Lonza is the world’s leading contract manufacturer of monoclonal antibodies and recombinant proteins and vaccine targets. We undertake highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries based on more than 20 years of experience in mammalian cell culture and proprietary technology for large-scale manufacture of innovative biopharmaceutical products.

We have contracts with many of the largest pharmaceutical companies in the world, and have customers ranging from international pharmaceutical companies and large biotechnology companies to emerging biotechnology companies.

Lonza is able to provide a complete development package, taking a product from vector construction and cell line development through to full-scale manufacture, including a full range of analytical services and regulatory support for clinical trials and in market supply.

Why work at Lonza?
We are proud to say that our people matter and are the cornerstone to our success. They come from many different countries and cultures and speak many languages. We value our diversity as a source of strength, seeking a business environment that fosters personal and professional growth and leadership values that take a holistic interpretation of human nature.

Our culture is centered on trust in each other and our people’s entrepreneurship. We appreciate a job well done and celebrate our successes. We reward our people with competitive salary and benefits packages together with far-reaching training and development programs. We believe that challenged and rewarded people work more productively, helping us meet our customers’ needs better and ensuring our products reaches more of the people who need them.

Our work revolves around emerging technologies that are groundbreaking, exciting and have a positive impact on humankind. Our environment is fast-paced, open to change, and dependent on individuals who are not afraid to get involved. We know that if our customers are successful, patients’ lives will be improved.

What is it like to work at Lonza’s New England facilities?
Lonza’s New England operations comprising the Hopkinton and Portsmouth sites are experiencing aggressive growth, both in our physical plant and in the size of our staff. Our environment is rapidly changing with a constant emphasis on finding innovative and better ways of providing our customers with products and services that are of exceptional quality, delivered on time, and exceed their expectations. We understand that every position in our company is critical in achieving this mission. We know that working together as a team requires mutual respect and accountability to each other.

Please visit us at www.lonza.com to learn more.


 Key Statistics


Email: contact.hopkinton@lonza.com
Ownership: Public

Web Site: Lonza Biologics Inc.
Employees:
Symbol: LONN.VX
 









 Company News
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014 8:42:07 AM
Lonza Biologics Inc. (LONN.VX) Lays Off 200 in MA 7/29/2013 8:17:19 AM
Genesis Biopharma, Inc. and Lonza Biologics Inc. Partner to Develop Contego™ 7/25/2011 6:26:53 AM
U.S.FDA Approves ORENCIA(R) (abatacept) Supplemental Biologics License Application (sBLA) For Third-Party Manufacturing Facility Lonza Biologics Inc. 5/8/2006 10:18:40 AM
Isotechnika Inc. Signs Manufacturing Agreement With Lonza Ltd.10/19/2005 5:11:38 PM
Transkaryotic Therapies, Inc. (TKT) (TKTX) Announces Manufacturing Agreement For Dynepo10/19/2005 5:11:25 PM
Lonza's L-Carnipure L-Carnitine Increases Fatty Acid Oxidation10/19/2005 5:11:19 PM
Lonza Group Files Patent Infringement Lawsuit Against Nutraceutical International Corporation10/19/2005 5:10:52 PM
Chromos Molecular Systems Inc. (CC:CHR) Extends Collaboration Agreement With Lonza Biologics Inc.10/19/2005 5:10:37 PM
Genentech (DNA) And Lonza, Inc. Announce Manufacturing Agreement10/19/2005 5:09:31 PM
12